journal article·2020-07-28

Photoactivated H2 Nanogenerator for Enhanced Chemotherapy of Bladder Cancer

Rui Sun, Xiaocen Liu, Guangzhi Li, Hui Wang, Yongxiang Luo, Guixiao Huang, Xisheng Wang, Guohua Zeng, Zhuang Liu, Song Wu

ACS Nano· Volume 14· Issue 7
Publisher page

Abstract

Hydrogen gas can mitigate oxidative stress in many diseases and is regarded to be safe and free of side effects. Inspired by a metalloenzyme in a variety of microorganisms, here, we propose a photoactivated H2 nanogenerator that comprises a fluorinated chitosan (FCS), a chemotherapeutic drug (gemcitabine, GEM), and a catalyst of H2 production ([FeFe]TPP) that can form self-assembled [FeFe]TPP/GEM/FCS nanoparticles (NPs). The [FeFe]TPP/GEM/FCS NPs exhibit excellent transmucosal and tumor cell penetration capacities after intravesical instillation into the bladder and can efficiently produce H2 gas in situ upon 660 nm laser irradiation, which significantly enhances the efficacy of hydrogen chemotherapy of cancer in vitro and in vivo. Moreover, we discover that H2 gas in hydrogen chemotherapy can inhibit mitochondrial function, hinder ATP synthesis, and cause a reduction of the P-gp efflux pump function, which finally attenuates P-gp protein drug transport capacity in cancer cells. This photoactivated H2 evolution in situ to improve the therapeutic efficacy of chemotherapy of bladder cancer may present an effective hydrogen chemotherapy strategy for cancer treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hydrogen's biological and therapeutic effects · Sulfur Compounds in Biology · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen 518000, China

Liaoning Key Laboratory of Proteomics, Dalian Medical University, Dalian 116044, China

Department of Urology, Longhua District Central Hospital, Shenzhen 518110, China

Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China

Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou 215123, China

Department of Urology, The Second Hospital of Lanzhou University, Lanzhou 730030, China

Funding

Guangdong Science and Technology Department · Ministry of Science and Technology of the People's Republic of China · China Postdoctoral Science Foundation · National Natural Science Foundation of China · Shenzhen Key Laboratory Program · Special Funds for Strategic Emerging Industries Development in Shenzhen · Innovation Program of Shenzhen

References (62)

Show source-provided references
1. 10.3322/caac.2133210.3322/caac.21332 ↗
2. 10.1016/j.eururo.2018.02.01410.1016/j.eururo.2018.02.014 ↗
3. 10.1016/j.ctrv.2016.05.00210.1016/j.ctrv.2016.05.002 ↗
4. 10.3322/caac.2144210.3322/caac.21442 ↗
5. 10.1016/S0140-6736(16)30512-810.1016/S0140-6736(16)30512-8 ↗
6. 10.1002/cncr.2814710.1002/cncr.28147 ↗
7. 10.1111/j.1464-410X.2011.10638.x10.1111/j.1464-410X.2011.10638.x ↗
8. 10.4111/icu.2018.59.1.1010.4111/icu.2018.59.1.10 ↗
9. 10.1016/j.eururo.2015.05.05010.1016/j.eururo.2015.05.050 ↗
10. 10.1016/j.eururo.2016.05.04110.1016/j.eururo.2016.05.041 ↗
11. 10.1002/adma.20190474210.1002/adma.201904742 ↗
12. 10.1067/mcn.2001.11753910.1067/mcn.2001.117539 ↗
13. 10.1016/j.eururo.2017.06.03810.1016/j.eururo.2017.06.038 ↗
14. 10.1016/j.eursup.2011.03.00110.1016/j.eursup.2011.03.001 ↗
15. 10.1016/j.ejps.2015.03.00610.1016/j.ejps.2015.03.006 ↗
16. 10.3233/BLC-16005610.3233/BLC-160056 ↗
17. 10.1016/j.jconrel.2016.07.02410.1016/j.jconrel.2016.07.024 ↗
18. 10.1002/advs.20180000410.1002/advs.201800004 ↗
19. 10.1016/j.jconrel.2018.06.03610.1016/j.jconrel.2018.06.036 ↗
20. 10.1002/adma.20170532810.1002/adma.201705328 ↗
21. 10.1002/smll.20190093610.1002/smll.201900936 ↗
22. 10.1021/acsnano.9b0668910.1021/acsnano.9b06689 ↗
23. 10.1002/adfm.20190193210.1002/adfm.201901932 ↗
24. 10.1002/anie.20161068210.1002/anie.201610682 ↗
25. 10.1002/adma.20170382210.1002/adma.201703822 ↗
26. 10.1021/acsnano.6b0681510.1021/acsnano.6b06815 ↗
27. 10.1021/acsnano.8b0870010.1021/acsnano.8b08700 ↗
28. 10.1039/C7BM00699C10.1039/C7BM00699C ↗
29. 10.1002/adma.20180196410.1002/adma.201801964 ↗
30. 10.1002/anie.20181306610.1002/anie.201813066 ↗
31. 10.1186/s13618-015-0035-110.1186/s13618-015-0035-1 ↗
32. 10.1021/jacs.7b0749210.1021/jacs.7b07492 ↗
33. 10.1038/nm157710.1038/nm1577 ↗
34. 10.1021/acsami.7b0534610.1021/acsami.7b05346 ↗
35. 10.1016/j.brainres.2010.02.04610.1016/j.brainres.2010.02.046 ↗
36. 10.1016/j.neulet.2009.02.01610.1016/j.neulet.2009.02.016 ↗
37. 10.1016/j.apmt.2018.01.00810.1016/j.apmt.2018.01.008 ↗
38. 10.1021/acsnano.9b0512410.1021/acsnano.9b05124 ↗
39. 10.1038/s41467-018-06630-210.1038/s41467-018-06630-2 ↗
40. 10.1159/00048973710.1159/000489737 ↗
41. 10.1038/1660110.1038/16601 ↗
42. 10.1126/science.282.5395.184210.1126/science.282.5395.1842 ↗
43. 10.1021/cr400581410.1021/cr4005814 ↗
44. 10.1039/C8SC05293J10.1039/C8SC05293J ↗
45. 10.1002/anie.20050360210.1002/anie.200503602 ↗
46. 10.1021/ic702010w10.1021/ic702010w ↗
47. 10.1021/jp710498v10.1021/jp710498v ↗
48. 10.1021/cr800542q10.1021/cr800542q ↗
49. 10.1186/2045-9912-2-110.1186/2045-9912-2-1 ↗
50. 10.1097/01.ju.0000074710.96154.c910.1097/01.ju.0000074710.96154.c9 ↗
51. 10.1016/j.drup.2016.03.00110.1016/j.drup.2016.03.001 ↗
52. 10.1248/bpb.b17-0072510.1248/bpb.b17-00725 ↗
53. 10.1038/s41568-018-0005-810.1038/s41568-018-0005-8 ↗
54. 10.1016/j.canlet.2015.10.01010.1016/j.canlet.2015.10.010 ↗
55. 10.1016/j.bbamem.2006.06.00410.1016/j.bbamem.2006.06.004 ↗
56. 10.1002/bdd.204710.1002/bdd.2047 ↗
57. 10.3390/cancers1106076110.3390/cancers11060761 ↗
58. 10.3390/ijms1907198510.3390/ijms19071985 ↗
59. 10.1158/0008-5472.CAN-08-274710.1158/0008-5472.CAN-08-2747 ↗
60. 10.1016/bs.acr.2018.02.00210.1016/bs.acr.2018.02.002 ↗
61. 10.1016/j.mito.2014.09.00210.1016/j.mito.2014.09.002 ↗
62. 10.1016/j.yjmcc.2016.04.01210.1016/j.yjmcc.2016.04.012 ↗